These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16285227)

  • 1. Management of patients with muscle-invasive and metastatic bladder cancer.
    Henry NL; MacVicar G; Hussain M
    Oncology (Williston Park); 2005 Sep; 19(10):1333-42; discussion 1342, 1347, 1350 passim. PubMed ID: 16285227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer.
    Ennis RD; Petrylak DP; Singh P; Bagiella E; O'Toole KM; Benson MC; Olsson CA
    J Urol; 2000 May; 163(5):1413-8. PubMed ID: 10751847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy for bladder cancer.
    Sonpavde G; Lerner SP
    Oncology (Williston Park); 2007 Dec; 21(14):1673-81; discussion 1686-8, 1691, 1694. PubMed ID: 18247016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical analysis of contemporary clinical research in muscle-invasive and metastatic urothelial cancer: a report from the Bladder Cancer Advocacy Network Clinical Trials Working Group.
    Galsky MD; Hendricks R; Svatek R; Bangs R; Hoffman-Censits J; Clement J; Dreicer R; Guancial E; Hahn N; Lerner SP; O'Donnell PH; Quale DZ; Siefker-Radtke A; Shipley W; Sonpavde G; Vaena D; Vinson J; Rosenberg J
    Cancer; 2013 Jun; 119(11):1994-8. PubMed ID: 23456777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining surgery and chemotherapy for invasive bladder cancer: current and future directions.
    Amiel GE; Lerner SP
    Expert Rev Anticancer Ther; 2006 Feb; 6(2):281-91. PubMed ID: 16445380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open to debate. The motion: perioperative chemotherapy in muscle invasive bladder cancer improves survival.
    Bellmunt J; Hautmann RE
    Eur Urol; 2008 Nov; 54(5):1192-7. PubMed ID: 18707804
    [No Abstract]   [Full Text] [Related]  

  • 7. SNAI1 protein expression is an independent negative prognosticator in muscle-invasive bladder cancer.
    Keck B; Wach S; Goebell PJ; Kunath F; Bertz S; Lehmann J; Stöckle M; Taubert H; Wullich B; Hartmann A
    Ann Surg Oncol; 2013 Oct; 20(11):3669-74. PubMed ID: 23807662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical factors influence bladder cancer outcomes: a cooperative group report.
    Herr HW; Faulkner JR; Grossman HB; Natale RB; deVere White R; Sarosdy MF; Crawford ED
    J Clin Oncol; 2004 Jul; 22(14):2781-9. PubMed ID: 15199091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of muscle-invasive bladder cancer: progress and new challenges.
    Herring JC; Kamat AM
    Expert Rev Anticancer Ther; 2004 Dec; 4(6):1047-56. PubMed ID: 15606332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological response to neoadjuvant chemotherapy for muscle-invasive micropapillary bladder cancer.
    Meeks JJ; Taylor JM; Matsushita K; Herr HW; Donat SM; Bochner BH; Dalbagni G
    BJU Int; 2013 Jun; 111(8):E325-30. PubMed ID: 23384236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adjuvant polychemotherapy after radical cystectomy of metastatic bladder cancer].
    Stöckle M
    Urologe A; 1994 Nov; 33(6):568-75. PubMed ID: 7817458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer.
    Muramaki M; Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
    Int J Urol; 2008 Apr; 15(4):314-8. PubMed ID: 18380818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is adjunctive systemic chemotherapy after cystectomy for T2N+ disease of therapeutic benefit?
    Galsky MD; Tagawa ST; Shariat SF
    J Urol; 2012 Aug; 188(2):358-60. PubMed ID: 22704119
    [No Abstract]   [Full Text] [Related]  

  • 15. The expression profile of p14, p53 and p21 in tumour cells is associated with disease-specific survival and the outcome of postoperative chemotherapy treatment in muscle-invasive bladder cancer.
    Aljabery F; Shabo I; Gimm O; Jahnson S; Olsson H
    Urol Oncol; 2018 Dec; 36(12):530.e7-530.e18. PubMed ID: 30539751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder.
    Blick C; Hall P; Pwint T; Al-Terkait F; Crew J; Powles T; Macaulay V; Munro N; Douglas D; Kilbey N; Protheroe A; Chester JD
    Cancer; 2012 Aug; 118(16):3920-7. PubMed ID: 22614698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
    Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
    Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapidly alternating chemotherapy and radiotherapy instead of cystectomy for the treatment of muscle-invasive carcinoma of the urinary bladder: long term results of a pilot study.
    Vikram B; Chadha M; Malamud SC; Hecht H; Grabstald H
    Cancer; 1998 Mar; 82(5):918-22. PubMed ID: 9486582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy in muscle-invasive bladder carcinoma: a pooled analysis from phase III studies.
    Ruggeri EM; Giannarelli D; Bria E; Carlini P; Felici A; Nelli F; Gallucci M; Cognetti F; Pollera CF
    Cancer; 2006 Feb; 106(4):783-8. PubMed ID: 16419069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.